Background Closed-loop artificial pancreas systems have been in development for several
years, including assessment in numerous varied outpatient clinical trials. We aimed to …

Pancreatic cystic neoplasms (PCN) are a heterogeneous group of pancreatic cysts that
include intraductal papillary mucinous neoplasms, mucinous cystic neoplasms, serous cystic …

Background Tracking national progress in diabetes care may aid in the evaluation of past
efforts and identify residual gaps in care. Methods We analyzed data for adults with self …

ISPAD Clinical Practice Consensus Guidelines 2018: Diabetes technologies Page 1 ISPAD
CLINICAL PRACTICE CONSENSUS GUIDELINES ISPAD Clinical Practice Consensus …

In this two-part Bench to Clinic narrative, recent advances in both the preclinical and clinical
aspects of artificial pancreas (AP) development are described. In the preceding Bench …

Abstract Since Banting and Best isolated insulin in the 1920s, dramatic progress has been
made in the treatment of type 1 diabetes mellitus (T1DM). However, dose titration and timely …

OBJECTIVE The rapid insulin-alone artificial pancreas improves glycemia in type 1 diabetes
but daytime control remains suboptimal. We propose two novel dual-hormone artificial …

Background The artificial pancreas is an emerging technology for the treatment of type 1
diabetes and two configurations have been proposed: single-hormone (insulin alone) and …

OBJECTIVE To evaluate feasibility, safety, and efficacy of overnight closed-loop insulin
delivery in free-living youth with type 1 diabetes. RESEARCH DESIGN AND METHODS …

The artificial pancreas is a long-awaited goal for the management of type 1 diabetes, and its
development was recently triggered by the development of continuous glucose sensors …